other material
confidence high
sentiment negative
materiality 0.60
NRX Pharmaceuticals, Inc. (NRXP): auditor change — NRX Pharmaceuticals dismisses KPMG as auditor, appoints Salberg & Company
NRX Pharmaceuticals, Inc.
- KPMG dismissed effective Nov 15, 2023; no adverse opinions or disagreements in prior years.
- KPMG reports included a going concern paragraph for years ended Dec 31, 2022 and 2021.
- Material weakness in segregation of duties identified for 2021 and quarters of 2022, remediated by Dec 31, 2022.
- Salberg & Company appointed as independent auditor for fiscal year 2023 effective Nov 17, 2023.
- No prior consultations with Salberg on accounting principles or reportable events.